Financial OutlookDecreasing price target to $1.00 reflects updated adoption assumptions for protein sequencing.
Market RisksRisks include clinical, technology, regulatory, manufacturing, commercial, legal and intellectual property, competition, and dilution.
Product PerformancePlacements of QSI's Platinum protein sequencer were modestly below expectations.